X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/09/2859907/0/en/NewAmsterdam-Pharma-Enrolls-Over-9-000-Patients-in-Pivotal-Phase-3-PREVAIL-Global-Cardiovascular-Outcome-Trial-Evaluating-the-Effect-of-Obicetrapib-in-Patients-with-Established-Ath.html
https://www.fiercebiotech.com/biotech/acc-newamsterdam-ceo-hopes-amgen-castoff-can-help-manage-heart-disease-slashing-small-ldl
https://www.globenewswire.com/news-release/2024/04/01/2855125/0/en/NewAmsterdam-Pharma-Announces-the-Appointment-of-Juliette-Audet-as-Chief-Business-Officer.html
https://www.globenewswire.com/news-release/2024/03/25/2851558/0/en/NewAmsterdam-Pharma-to-Present-New-Analysis-from-the-Phase-2-ROSE2-Trial-Evaluating-Obicetrapib-in-Combination-with-Ezetimibe-at-2024-American-College-of-Cardiology-Congress.html
https://www.globenewswire.com//news-release/2024/03/12/2844471/0/en/NewAmsterdam-Pharma-Doses-First-Patient-in-Phase-3-TANDEM-Clinical-Trial-Evaluating-Fixed-Dose-Combination-of-Obicetrapib-and-Ezetimibe-in-Patients-with-HeFH-and-or-ASCVD.html
https://www.globenewswire.com//news-release/2024/02/28/2836899/0/en/NewAmsterdam-Pharma-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/02/26/2835093/0/en/NewAmsterdam-Pharma-to-Participate-in-Upcoming-Investor-Conferences-in-March.html
https://www.globenewswire.com//news-release/2024/02/14/2828755/0/en/NewAmsterdam-Pharma-Announces-Pricing-of-175-3-Million-Public-Offering-of-Ordinary-Shares-and-Pre-Funded-Warrants.html
https://www.globenewswire.com//news-release/2024/02/13/2828622/0/en/NewAmsterdam-Pharma-Announces-Commencement-of-Public-Offering-of-Ordinary-Shares-and-Pre-Funded-Warrants.html
https://www.globenewswire.com//news-release/2024/02/01/2822425/0/en/NewAmsterdam-Pharma-to-Present-at-Guggenheim-Healthcare-Talks-6th-Annual-Biotechnology-Conference.html
Market Place
Share 
